Target intelligence / Profile preview

Fibroblast cellular environment

Molecular classification
Other
01

Overview

The fibroblast cellular environment, also known as the fibroblast niche or stroma, is a complex biological system comprising fibroblasts, the extracellular matrix (ECM), and a variety of secreted growth factors and cytokines (Source: NIH, StatPearls). Fibroblasts are the primary cells responsible for synthesizing ECM components like collagen and elastin, which provide structural support to tissues and play a vital role in wound healing and tissue repair. In pathological conditions such as idiopathic pulmonary fibrosis or the tumor microenvironment in cancer, fibroblasts become chronically activated into myofibroblasts, leading to excessive ECM deposition and tissue stiffening. While the environment itself is not a single molecular target, specific components within it—such as the TGF-beta receptor, Fibroblast Activation Protein (FAP), and various integrins—are targeted by drugs like Nintedanib and Pirfenidone to treat fibrotic diseases (Source: PubMed, PMID: 28951313). Understanding the dynamics of this environment is crucial for developing therapies that can reverse fibrosis or disrupt the supportive stroma that protects tumor cells from chemotherapy.

Other names
Fibroblast microenvironmentFibroblast nicheStromaConnective tissue microenvironment
02

Mechanism of action

Therapeutic strategies targeting the fibroblast cellular environment involve the inhibition of pro-fibrotic signaling pathways, such as TGF-beta and PDGF, or the modulation of extracellular matrix-modifying enzymes like lysyl oxidase-like 2 (LOXL2) to prevent excessive tissue scarring and remodeling (Source: PubMed, PMID: 30635081).

03

Biological functions

Extracellular matrix organizationWound healingTissue remodelingStructural supportCell-cell communication
04

Disease associations

FibrosisCancerInflammationCardiovascular diseaseScleroderma
05

Safety considerations

Impaired wound healingSystemic connective tissue toxicityOff-target effects on healthy tissue repairPotential for increased bleeding or tissue friability
06

Interacting drugs

Nintedanib

3 more in the full profile.

07

Biomarkers

Fibroblast activation protein (FAP)Alpha-smooth muscle actin (alpha-SMA)Type I collagenPro-collagen III N-terminal peptide (PIIINP)

Beyond the preview

Go deeper on Fibroblast cellular environment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibroblast cellular environment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call